Reply: BAL lymphocyte percentage is as good as the company it keeps

Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson

Source: Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
Journal Issue: February
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson. Reply: BAL lymphocyte percentage is as good as the company it keeps. Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018
Year: 2018

Pulmonary dendritic cells: playing ball in the BAL?
Source: Eur Respir J 2007; 30: 823-824
Year: 2007

Normal values for bronchoalveolar lavage (BAL) differential cell count and lymphocyte subpopulations
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021

Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010

Which CD8+ T-cells in asthma? Attacking or defending?
Source: Eur Respir J 2016; 48: 287-290
Year: 2016

Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021

BAL cell counts in the diagnosis of lung diseases: is there a gain in information?
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Year: 2002

Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Year: 2004

Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019

T lymphocyte subsets in bronchoalveolar lavage: A flow cytometric and its importance in the differntial diagnosis of sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 265s
Year: 2003

The meaning of a high monocyte to lymphocyte ratio in tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019

Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

COPD treatment choices based on blood eosinophils: are we there yet?
Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019
Year: 2019

Treg cells are expanded among bronchoalveolar lymphocytes in healthy tuberculosis contacts with positive interferon-γ release assay responses
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011

Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019

Elevated blood eosinophils in bronchiectasis: A distinct phenotype?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021

Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021